Search





Search





Markets
/
Stocks
/
nuvb
/

Nuvation Bio Inc

NUVB

Add to Watchlist

6.330USD

-0.360-5.37%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.20BMarket Cap

LossP/E TTM

Nuvation Bio Inc

6.330

-0.360-5.37%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

NUVB Cash Flow Statement

You can access the annual and quarterly cash flow statements of Nuvation Bio Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

111.89%5.07M

35.78%-29.73M

-70.14%-52.89M

-29.08%-48.18M

-171.47%-42.63M

-208.08%-46.30M

-92.42%-31.09M

-113.46%-37.32M

18.77%-15.70M

7.05%-15.03M

42.49%-16.16M

35.04%-17.48M

22.46%-19.33M

31.14%-16.17M

-113.66%-28.09M

-59.94%-26.92M

-69.24%-24.93M

-81.51%-23.48M

-63.57%-13.15M

-146.20%-16.83M

-68.96%-14.73M

-37.69%-12.94M

---8.04M

---6.84M

---8.72M

---9.40M

Net income from continuing operations

110.14%5.40M

25.99%-36.59M

-35.38%-55.79M

87.24%-59.01M

-259.90%-53.24M

-258.63%-49.45M

-109.73%-41.21M

-2140.76%-462.49M

31.92%-14.79M

33.86%-13.79M

27.77%-19.65M

40.79%-20.64M

-2.03%-21.73M

17.06%-20.84M

-23.77%-27.20M

-80.30%-34.86M

-4.37%-21.29M

-89.26%-25.13M

-99.19%-21.98M

-124.83%-19.33M

-133.27%-20.40M

-32.65%-13.28M

---11.03M

---8.60M

---8.75M

---10.01M

Operating gains losses

72.90%536.00K

146.12%539.00K

229.63%534.00K

45.90%356.00K

434.48%310.00K

298.18%219.00K

194.55%162.00K

335.71%244.00K

3.57%58.00K

12.24%55.00K

-1.79%55.00K

16.67%56.00K

21.74%56.00K

13.95%49.00K

-20.00%56.00K

17.07%48.00K

53.33%46.00K

59.26%43.00K

169.23%70.00K

57.69%41.00K

25.00%30.00K

237.50%27.00K

--26.00K

--24.00K

--8.00K

Other non-cash items

521.28%4.47M

302.68%3.48M

269.60%3.62M

-100.32%-1.33M

62.84%-1.06M

47.78%-1.72M

37.81%-2.13M

13147.48%422.61M

-32.07%-2.86M

-786.25%-3.29M

-555.91%-3.43M

-279.74%-3.24M

-222.12%-2.16M

-120.75%-371.00K

-40.00%753.00K

62.93%1.80M

-59.86%1.77M

269.42%1.79M

709.68%1.25M

821.67%1.11M

2437.36%4.42M

243.26%484.00K

--155.00K

--120.00K

--174.00K

--141.00K

Change in working capital

-516.75%-11.50M

6.98%-6.28M

-274.08%-8.66M

103.17%194.00K

159.86%2.76M

-368.15%-6.75M

171.90%4.97M

-1458.09%-6.13M

-1441.47%-4.61M

-883.15%-1.44M

141.58%1.83M

-87.77%451.00K

89.76%-299.00K

-76.53%184.00K

-189.92%-4.40M

1346.28%3.69M

-397.61%-2.92M

167.53%784.00K

89.17%4.89M

-125.08%-296.00K

-18.59%-587.00K

-328.54%-1.16M

--2.59M

--1.18M

---495.00K

--508.00K

-Change in receivables

-161.15%-6.62M

54.23%-5.51M

-2888.75%-7.17M

-546.69%-1.22M

1964.03%10.83M

-1699.85%-12.04M

-0.84%-240.00K

152.11%272.00K

-374.06%-581.00K

-395.56%-669.00K

-174.84%-238.00K

-198.29%-522.00K

-61.17%212.00K

88.98%-135.00K

73.77%318.00K

82.18%-175.00K

609.09%546.00K

-87.31%-1.23M

-30.15%183.00K

-506.17%-982.00K

-73.45%77.00K

-204.19%-654.00K

--262.00K

---162.00K

--290.00K

---215.00K

-Change in inventory

-31564.29%-4.43M

---5.70M

---5.16M

---538.00K

---14.00K

----

-Change in prepaid expenses

-287.76%-4.44M

-160.33%-2.61M

88.06%-669.00K

-95.54%158.00K

78.32%-1.14M

196.91%4.33M

-1109.91%-5.61M

2248.34%3.55M

-3951.82%-5.28M

14.27%1.46M

-79.47%555.00K

251.16%151.00K

103.26%137.00K

303.03%1.27M

85.46%2.70M

-93.55%43.00K

-7.31%-4.20M

-59.39%-628.00K

3656.10%1.46M

-26.22%667.00K

-227.17%-3.91M

-629.63%-394.00K

---41.00K

--904.00K

---1.20M

---54.00K

-Change in other current assets

2508.97%3.78M

97.64%-145.00K

1104.38%7.15M

-399900.00%-8.00M

129.71%145.00K

-204466.67%-6.14M

201.19%594.00K

---2.00K

---488.00K

---3.00K

---587.00K

----

--0.00

--283.00K

----

-Change in other current liabilities

81.53%-426.00K

-83.32%969.00K

-808.39%-4.33M

-58.09%-2.20M

---2.31M

--5.81M

---477.00K

---1.39M

----

-1745.45%-181.00K

-86.67%4.00K

-52.38%10.00K

-88.10%10.00K

0.00%11.00K

--30.00K

--21.00K

--84.00K

--11.00K

Cash from non-recurring investing activities

Cash from operating activities

111.89%5.07M

35.78%-29.73M

-70.14%-52.89M

-29.08%-48.18M

-171.47%-42.63M

-208.08%-46.30M

-92.42%-31.09M

-113.46%-37.32M

18.77%-15.70M

7.05%-15.03M

42.49%-16.16M

35.04%-17.48M

22.46%-19.33M

31.14%-16.17M

-113.66%-28.09M

-59.94%-26.92M

-69.24%-24.93M

-81.51%-23.48M

-63.57%-13.15M

-146.20%-16.83M

-68.96%-14.73M

-37.69%-12.94M

---8.04M

---6.84M

---8.72M

---9.40M

Investing cash flow

Net cash from continuing investing activities

-33.33%48.00K

784.62%89.00K

5313.51%8.01M

--181.00K

166.67%72.00K

-1200.00%-13.00K

572.73%148.00K

-100.00%0.00

125.00%27.00K

-101.69%-1.00K

-77.08%22.00K

-88.72%22.00K

71.43%12.00K

-56.30%59.00K

231.03%96.00K

4775.00%195.00K

-93.86%7.00K

400.00%135.00K

93.33%29.00K

-33.33%4.00K

17.53%114.00K

-92.01%27.00K

--15.00K

--6.00K

--97.00K

--338.00K

Capital expenditures

-33.33%48.00K

--89.00K

5313.51%8.01M

--181.00K

166.67%72.00K

----

572.73%148.00K

-100.00%0.00

125.00%27.00K

-80.00%13.00K

-78.64%22.00K

-88.72%22.00K

71.43%12.00K

-51.85%65.00K

255.17%103.00K

4775.00%195.00K

-93.86%7.00K

400.00%135.00K

93.33%29.00K

-33.33%4.00K

17.53%114.00K

-92.01%27.00K

--15.00K

--6.00K

--97.00K

--338.00K

Net cash flow from disposal of fixed assets

-33.33%48.00K

784.62%89.00K

-91.89%12.00K

--181.00K

166.67%72.00K

-1200.00%-13.00K

572.73%148.00K

-100.00%0.00

125.00%27.00K

-101.69%-1.00K

-77.08%22.00K

-88.72%22.00K

71.43%12.00K

-56.30%59.00K

231.03%96.00K

4775.00%195.00K

-93.86%7.00K

400.00%135.00K

93.33%29.00K

-33.33%4.00K

17.53%114.00K

-92.01%27.00K

--15.00K

--6.00K

--97.00K

--338.00K

Net cash flow from intangible asset transactions

----

--0.00

--8.00M

----

Net cash flow from business transactions

----

100.00%0.00

--0.00

----

---1.00K

--0.00

--19.86M

----

Net cash flow from investment products

-180.34%-43.59M

68.12%87.17M

-402.79%-88.61M

153.10%55.06M

616.79%54.25M

56.36%51.85M

405.79%29.26M

-41.79%21.75M

114.56%7.57M

252.33%33.16M

-114.88%-9.57M

39.28%37.37M

-837.66%-51.98M

88.49%-21.77M

170.12%64.30M

115.54%26.83M

-470.96%-5.54M

-92.52%-189.13M

-1503.75%-91.69M

-1694.25%-172.59M

-109.07%-971.00K

-1397.21%-98.24M

--6.53M

--10.83M

--10.71M

--7.57M

Net cash flow from other investing activities

----

100.00%0.00

--0.00

----

---91.00K

--0.00

---7.34M

----

Cash from non-current investing activities

Net cash flow from investing activities

-180.54%-43.64M

68.20%87.08M

-431.85%-96.62M

60.11%54.88M

618.40%54.18M

56.11%51.77M

403.54%29.12M

-8.23%34.27M

114.50%7.54M

251.92%33.16M

-114.94%-9.59M

40.22%37.35M

-836.70%-52.00M

88.47%-21.83M

170.00%64.20M

115.43%26.63M

-411.61%-5.55M

-92.61%-189.26M

-1507.43%-91.72M

-1695.18%-172.60M

-110.23%-1.08M

-1458.19%-98.27M

--6.52M

--10.82M

--10.61M

--7.24M

Financing cash flow

Cash flow from continuous financing activities

-91.97%44.00K

995.89%8.06M

132.57%501.00K

6938.68%193.42M

2509.52%548.00K

-850.00%-900.00K

-2097.40%-1.54M

1966.17%2.75M

-92.95%21.00K

-70.52%120.00K

-70.16%77.00K

103.69%133.00K

-93.01%298.00K

-24.35%407.00K

906.25%258.00K

-6419.30%-3.60M

-99.32%4.26M

-99.59%538.00K

-106.40%-32.00K

--57.00K

--624.96M

54458.61%132.63M

--500.00K

----

---244.00K

Net cash flow from debt Issuance/repayment

100.00%0.00

100.10%2.00K

100.00%0.00

--48.73M

---534.00K

---2.06M

---3.21M

----

---244.00K

Net cash flow from common stock issuance/repurchase

----

143.57%777.00K

--0.00

--533.00K

----

165.83%319.00K

--0.00

----

25.00%120.00K

--0.00

-54.45%133.00K

----

-68.83%96.00K

--0.00

--292.00K

----

--308.00K

----

--0.00

Proceeds from stock option exercised by employees

-16.08%908.00K

817.74%7.71M

-66.59%558.00K

-60.46%762.00K

5052.38%1.08M

--840.00K

2068.83%1.67M

--1.93M

-92.95%21.00K

-100.00%0.00

-70.16%77.00K

-100.00%0.00

-5.10%298.00K

35.22%311.00K

760.00%258.00K

-70.53%56.00K

--314.00K

--230.00K

--30.00K

--190.00K

----

Net cash flow from other financing activities

---864.00K

---425.00K

---57.00K

17365.65%143.39M

----

--821.00K

----

-100.00%0.00

--0.00

100.00%0.00

-2869.92%-3.95M

-99.37%3.95M

100.00%0.00

---62.00K

---133.00K

--624.96M

-302.93%-3.02M

----

---750.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-91.97%44.00K

995.89%8.06M

132.57%501.00K

6938.68%193.42M

2509.52%548.00K

-850.00%-900.00K

-2097.40%-1.54M

1966.17%2.75M

-92.95%21.00K

-70.52%120.00K

-70.16%77.00K

103.69%133.00K

-93.01%298.00K

-24.35%407.00K

906.25%258.00K

-6419.30%-3.60M

-99.32%4.26M

-99.59%538.00K

-106.40%-32.00K

--57.00K

--624.96M

54458.61%132.63M

--500.00K

----

---244.00K

Net cash flow

Beginning cash balance

359.33%164.09M

229.26%98.90M

623.26%247.97M

39.02%47.98M

-16.24%35.72M

23.12%30.04M

-31.52%34.28M

14.76%34.51M

-57.81%42.65M

-82.41%24.39M

-51.07%50.06M

-71.69%30.07M

-23.65%101.10M

-59.76%138.69M

-77.24%102.32M

-83.38%106.21M

345.04%132.42M

4041.20%344.63M

4711.44%449.53M

11822.08%638.90M

757.74%29.75M

41.68%8.32M

--9.34M

--5.36M

--3.47M

--5.87M

Current period cash flow changes

-415.77%-38.70M

1046.28%65.19M

-3408.43%-149.07M

88985.78%199.99M

250.56%12.25M

-68.85%5.69M

83.45%-4.25M

-101.13%-225.00K

88.54%-8.14M

148.56%18.25M

-170.58%-25.67M

614.51%19.99M

-170.93%-71.03M

82.29%-37.59M

134.67%36.37M

97.95%-3.89M

-104.30%-26.22M

-1090.10%-212.21M

-10174.44%-104.90M

-4853.29%-189.37M

32130.11%609.15M

991.19%21.43M

---1.02M

--3.98M

--1.89M

---2.41M

Effect of exchange rate changes

-213.91%-172.00K

-120.05%-224.00K

91.37%-64.00K

-264.10%-128.00K

--151.00K

--1.12M

---742.00K

--78.00K

----

Ending cash balance

161.36%125.39M

359.33%164.09M

229.26%98.90M

623.26%247.97M

39.02%47.98M

-16.24%35.72M

23.12%30.04M

-31.52%34.28M

14.76%34.51M

-57.81%42.65M

-82.41%24.39M

-51.07%50.06M

-71.69%30.07M

-23.65%101.10M

-59.76%138.69M

-77.24%102.32M

-83.38%106.21M

345.04%132.42M

4041.20%344.63M

4711.44%449.53M

11822.08%638.90M

757.74%29.75M

--8.32M

--9.34M

--5.36M

--3.47M

Free cash flow

111.76%5.02M

35.59%-29.82M

-94.99%-60.90M

-29.57%-48.36M

-171.47%-42.70M

-207.82%-46.30M

-93.07%-31.23M

-113.19%-37.32M

18.68%-15.73M

7.34%-15.04M

42.62%-16.18M

35.43%-17.51M

22.43%-19.34M

31.26%-16.23M

-113.97%-28.20M

-61.06%-27.11M

-67.99%-24.94M

-82.17%-23.62M

-63.63%-13.18M

-146.04%-16.83M

-68.39%-14.84M

-33.18%-12.96M

---8.05M

---6.84M

---8.81M

---9.73M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Nuvation Bio Inc Generate?



Nuvation Bio Inc generated -173.43M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Nuvation Bio Inc's Operating Cash Flow Change Year Over Year?



Nuvation Bio Inc's operating cash flow increased by -32.98% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Nuvation Bio Inc Spend on Capital Expenditures?



Nuvation Bio Inc spent 8.35M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Nuvation Bio Inc's Financing Cash Flow Changed?



Nuvation Bio Inc used 202.53M in financing activities in the latest quarter.

What is free cash flow and why does it matter for NUVB?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Nuvation Bio Inc’s free cash flow in the latest quarter?



Free cash flow was -181.78M reflecting a -39.22% change from the previous year.